Vicore Pharma Holding - ADR

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company focused on developing treatments for severe respiratory diseases, with particular emphasis on fibrotic lung conditions and related disorders. The company’s current portfolio is centered on novel small-molecule therapies designed to address disease pathways that contribute to inflammation, tissue remodeling, and lung function decline. Its work spans drug discovery and clinical development, with programs advancing through early- and mid-stage testing. Vicore Pharma Holding AB operates within the broader pharmaceutical market, where it contributes to innovation in respiratory medicine and targeted therapies for patients with significant unmet medical needs. The company is headquartered in Stockholm, Sweden, and its activities are focused on translating scientific research into therapeutic candidates for specialized disease areas.